At the end of the latest market close, Soligenix Inc. (SNGX) was valued at $1.17. In that particular session, Stock kicked-off at the price of $1.15 while reaching the peak value of $1.18 and lowest value recorded on the day was $1.15. The stock current value is $1.23.
Recently in News on June 10, 2021, Soligenix Receives Pediatric Investigational Plan Waiver for HyBryte™ in CTCL from the European Medicines Agency. Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received a Pediatric Investigation Plan (PIP) waiver from the European Medicines Agency (EMA) for HyBryte™ (SGX301 or hypericin), which has recently and successfully concluded a Phase 3, pivotal clinical study for the treatment of early stage cutaneous T-cell lymphoma (CTCL). You can read further details here
Soligenix Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.4800 on 02/16/21, with the lowest value was $0.8550 for the same time period, recorded on 05/13/21.
Soligenix Inc. (SNGX) full year performance was -46.58%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Soligenix Inc. shares are logging -58.86% during the 52-week period from high price, and 43.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.86 and $2.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3389395 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Soligenix Inc. (SNGX) recorded performance in the market was -8.59%, having the revenues showcasing -28.66% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 44.74M, as it employees total of 17 workers.
Analysts verdict on Soligenix Inc. (SNGX)
During the last month, 0 analysts gave the Soligenix Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.4792, with a change in the price was noted -0.18. In a similar fashion, Soligenix Inc. posted a movement of -12.58% for the period of last 100 days, recording 2,815,300 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SNGX is recording 0.59 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.57.
Soligenix Inc. (SNGX): Technical Analysis
Raw Stochastic average of Soligenix Inc. in the period of last 50 days is set at 51.65%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 81.46%. In the last 20 days, the company’s Stochastic %K was 87.50% and its Stochastic %D was recorded 84.45%.
Let’s take a glance in the erstwhile performances of Soligenix Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -8.59%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -50.42%, alongside a downfall of -46.58% for the period of the last 12 months. The shares increased approximately by 14.71% in the 7-day charts and went up by 13.59% in the period of the last 30 days. Common stock shares were lifted by -28.66% during last recorded quarter.